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Abstract. GPI-linked membrane folate receptors 
(MFRs) have been implicated in the receptor-mediated 
uptake of reduced folate cofactors and folate-based 
chemotherapeutic drugs. We have studied the biosyn- 
thetic transport to and internalization of MFR isoform 
et in KB-cells. MFR-et was synthesized as a 32-kD pro- 
tein and converted in a maturely glycosylated 36-38-kD 
protein 1 h after synthesis. 32-kD MFR-a was com- 
pletely soluble in Triton X-100 at 0°C. In contrast, only 
33 % of the 36-38-kD species could be solubilized at 
these conditions whereas complete solubilization was 
obtained in Triton X-100 at 37°C or in the presence of 
saponin at 0°C. Similar solubilization characteristics 
were found when MFR-et at the plasma membrane was 
labeled with a crosslinkable 125I-labeled  photoaffinity- 
analog of folic acid as a ligand. Triton X-100-insoluble 
membrane domains containing MFR-a could be sepa- 
rated from soluble MFR-a on sucrose flotation gradi- 
ents. Only Triton X-100 soluble MFR-a was internalized 
from the plasma membrane. The reduced-folate-car- 
rier, an integral membrane protein capable of translo- 
cating (anti-)folates across membranes, was completely 
excluded from the Triton X-100-resistant membrane 
domains. Internalized MFR-a recycled slowly to the 
cell surface during which it remained soluble in Triton 
X-100 at 0°C. Using immunoelectron microscopy, we 
found MFR-o~ along the entire endocytic pathway: in 
clathrin-coated buds and vesicles, and in small and 
large endosomal vacuoles. In conclusion, our data indi- 
cate that a large fraction, if not all, of internalizing 
MFR-et bypasses caveolae. 
-METHYLTETRAHYDROFOLIC  acid is an essential vita- 
min for the biosynthesis of deoxythymidylic acid, pu- 
rines  and  the  amino  acids  methionine  and  serine 
(Antony, 1992).  For several  decades  the  folate-metabo- 
lism has been exploited as a target for chemotherapeutic 
treatment of a variety of cancers using cytotoxic folate-antag- 
onists  such  as  methotrexate  (Bertino,  1993).  Transport 
across membranes of (anti-)folates is one of the critical de- 
terminants in their chemotherapeutic effectiveness. Two 
functionally different  systems  have  been  implicated  in 
their  cellular  uptake:  (1)  the  Reduced-Folate-Carrier 
(RFC) 1 (Sirotnak,  1985),  which probably uses an anion- 
exchange mechanism to introduce (anti-)folates into the 
cytosol (Henderson et al., 1986), and (2) Membrane Folate 
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Receptors  (MFRs), which internalize (anti-)folates by a 
receptor-mediated process.  After internalization, folates 
are retained in the cytoplasm by polyglutamation (McGuire 
et al., 1980). 
The transport kinetics by and affinities for (anti-)folates 
of both  systems differ significantly (Ratnam  and  Freis- 
heim, 1990; Henderson, 1990; Anthony, 1992). The RFC 
has a  relatively high affinity for reduced folates and the 
antifolate methotrexate (Kin: 1-10 txM) but has a relatively 
poor affinity for the oxidized'folate, folic acid (Km: 200- 
400  ~M). In contrast, MFRs have high affinities for folic 
acid (K~: 0.1-1 nM) and reduced folates (Kd: 1-10 nM) but 
relatively low affinities for methotrexate (Ka >  100 nM). 
Both of these transport systems can be  expressed sepa- 
rately or complementary to each other in one cell (Jansen 
et al., 1989; Westerhof et al:, 1991, 1993,  1994). The func- 
tion of such simultaneous expression of both systems in 
one cell remains unclear. Although the cell and tissue dis- 
tribution of MFRs (Weitman et al., 1992; Ross et al., 1994) 
has  been  documented in  gre~iter detail  than  the  RFC 
(Matherly et al., 1994), both systems are constitutively ex- 
pressed in many tissues and ~celi types. Recently two cDNAs 
have been isolated encoding a protein with RFC-activity 
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1994), and human  (Williams  and Flintoff, 1995)  cDNA- 
libraries, predicting that the RFC is a glycosylated integral 
membrane protein that spans the membrane 12 times. 
While the translocation of folates by the RFC occurs di- 
rectly at the plasma membrane (Sirotnak, 1985), the up- 
take by MFRs is thought to occur after internalization of 
the receptors into the cells. Several cDNAs encoding at 
least three different isoforms of MFRs have been isolated 
(Ratnam et al., 1989; Elwood, 1989; Lacey et al., 1989; Sa- 
dasivan and Rothenberg, 1989; Brigle et al., 1991; Shen et 
al., 1994), and it has been well established that their prod- 
ucts are attached to membranes by a glycosyl-phosphati- 
dyl-inositol (GPI)-anchor (Lacey et al.,  1989;  Luhrs and 
Slomiany,  1989;  Alberti  et  al.,  1990).  In  general,  GPI- 
linked proteins are internalized by cells more slowly than 
integral membrane receptors and possibly through differ- 
ent  internalization  pathways  (Low,  1989;  Lisanti  et  al., 
1990; Bamezai et al.,  1992; Keller et al., 1992; Watts and 
Marsh,  1992).  Especially with  respect  to  the  uptake  of 
(anti-)folates, Anderson and colleagues have shown that 
in MA-104 monkey kidney cells MFR-c~ binds and inter- 
nalizes folates after which the receptor recycles to the cell 
surface. Furthermore, their study provided evidence that 
MFR-a works in tandem with a probenecid-sensitive car- 
rier  (Kamen  et  al.,  1988,  1991).  Electronmicroscopy in 
combination with these biochemical data led them to pro- 
pose a  model for the uptake of small molecules such as 
(anti-)folates, termed potocytosis (Rothberg et al., 1990a; 
Anderson, 1993a). In this model MFR-~ is entirely clus- 
tered  in  caveolae,  which  were  originally  described  as 
small,  non-clathrin-coated  invaginations  at  the  plasma 
membrane (Palade and Bruns, 1968) and serve to concen- 
trate folates. After sealing of the caveolae, rapid acidifica- 
tion of the caveolar content would cause dissociation of 
folates from MFR-a after which a putative carrier protein 
would  translocate the folates across  the  membrane into 
the cytosol. During this process caveolae remain attached 
to the plasma membrane. To complete the cycle the caveo- 
lae  open  and  expose MFR-c~  to  the  extracellular space 
again. Caveolae differ from clathrin-coated buds and vesi- 
cles which pinch off from the plasma membrane after un- 
coating the fuse with the endosomal system. However, re- 
cently it was shown that clustering of MFR-et and other 
GPI-linked proteins in caveolae could be induced by spe- 
cific antibodies (Mayor et al., 1994). Since the clustering of 
MFR-a  in  caveolae,  as  reported  by  Anderson  and  col- 
leagues, could have been induced by antibody binding, the 
mechanism by which MFR-a mediates the uptake of (anti-) 
folates into cells remains to be established. In addition, it 
has been reported that internalization of MFR-a and other 
GPI-linked proteins proceeds via clathrin-coated or non- 
clathrin-coated vesicles, both capable  of fusing with the 
entire endosomal system (Hjelle et al., 1991; Nykjzer et al., 
1992;  Watts  and  Marsh,  1992;  Van  Deurs  et  al.,  1993; 
Sandvig and van Deurs, 1994). 
Caveolae  are  thought  to  exist  in  many  different cell 
types (Severs, 1988; Rothberg et al., 1992). The integrity of 
caveolae depends on the presence of cholesterol (Roth- 
berg et al.,  1990b;  Cerneus et al.,  1993).  Caveolae have 
been shown to contain multiple GPI-linked proteins (Ying 
et al.,  1992), an IP3-sensitive Ca2+-channel  (Fujimoto et 
al.,  1992),  and  an  ATP-sensitive  Ca2÷-pump  (Fujimoto, 
1993).  Caveolin is a major constituent of caveolae (Glen- 
ney and Soppet, 1992; Rothberg et al., 1992). VIP21, which 
was shown to be identical to caveolin (Glenney, 1992), has 
also  been  localized to  the trans-Golgi network  and  has 
been proposed to be part of the biosynthetic apical sorting 
machinery in epithelial cells (Kurzchalia et al., 1992; Du- 
pree et al., 1993). Differential solubilization of GPI-linked 
proteins  in  non-ionic  detergents  (for  review  see  Low, 
1989) has also been implicated in their sorting to the apical 
domain of the plasma membrane in epithelial cells (Brown 
and Rose, 1992; Cerneus et al.,  1993; Garcia et al.,  1993). 
In this model GPI-linked proteins together with glycosphin- 
golipids form membrane domains in the trans-Golgi net- 
work, which are then targeted to the apical domain of the 
plasma  membrane,  as  initially proposed by Simons  and 
van Meer (1988). Recently, biochemical methods based on 
the  differential solubilization characteristics in non-ionic 
detergents such as Triton X-100 have become available to 
isolate membrane domains,  which  are  enriched in  GPI- 
linked proteins and may represent caveolae (Cinek  and 
Horejsi, 1992; Sargiacomo et al., 1993; Fiedler et al., 1993; 
Lisanti et al.,  1994a;  Chang  et al.,  1994).  In  addition  to 
GPI-linked  proteins  isolated  Triton  X-100-insoluble 
membrane domains also contained GTP-binding proteins 
and protein-tyrosine kinases. This has led to the proposi- 
tion of another function for caveolae, i.e., their involve- 
ment in signal transduction (Anderson, 1993a,b;  Lisanti et 
al., 1994b). 
In the present study, we have used iodinated crosslink- 
able photoaffinity analogs of folic acid and the antifolate 
methotrexate to study the trafficking of functional MFR-a 
and RFC molecules. We have found correlations between 
the  solubilization  characteristics  of  GPI-linked  MFR-e~ 
with  its  biosynthesis, internalization,  and  recycling. Our 
results  show  that  MFR-a  present  in  detergent-resistant 
membrane  domains  are  excluded  from  internalization. 
Only a small amount of Triton X-100 soluble MFR-et is in- 
ternalized by the cells, at least in part via clathrin-coated 
vesicles, and reaches the endosomal compartments. 
Materials and Methods 
Cell Culture and Biosynthetic Labeling 
KB nasopharyngeal carcinoma, and leukemic CCRF-CEM-7A (Jansen et 
al., 1990b) cells were cultured in a  5%  CO2 atmosphere in RPMI  1640 
without folic acid (GIBCO BRL, Gaithersburg, MD), supplemented with 
10%  dialyzed  FCS  and  1  nM of folinic  acid  ([6S]-5-formyltetrahydro- 
folate). 24 h  before each experiment the folinic acid was removed from 
the cells by changing the medium. For metabolic labeling, cells were de- 
pleted  from  methionine,  pulse  labeled  at  37°C  with  3.7  MBq/ml  of 
[35S]methionine (Tran-S-label, 185 MBq/ml, 40 TBq/mmol, ICN Biomedi- 
cals, Inc., CA) for 15 min and chased for the indicated time periods at 
37°C in culture medium containing 100 ixM unlabeled methionine (Rijn- 
boutt et al., 1992).  The media were prewarmed and equilibrated in a 5% 
CO2-atmosphere before use. Next the cells were lysed in PBS containing 
1% Triton X-100 and 1 mM PMSF at 0°C and aliquots of the lysates were 
incubated at 37 or 0°C in the absence or presence of 0.2% saponin. Deter- 
gent-insoluble material was subsequently removed by centrifugation at 
10,000 g at 4°C. Finally, the lysates were immunoprecipitated for MFR-a 
and immunoprecipitations were analyzed by separation on SDS-PAGE. 
Quantitation of the gels was performed using a Phospho-Imager (Molecu- 
lar Dynamics, Sunnyvale, CA). 
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N~-Pteroyl-N~(4'-azidosalicyl)-L-Lysine was prepared by the reaction of 
N~-[Nl°-(trifluoroacetyl)pteroyl]-L-Lysine (McAlinden et al.,  1991)  and 
4-azidosalicylic acid succinimyl ester in a molar ratio of 1:1.5 at 16°C in 
subdued light (Price et al., 1986).  The trifluoroacetyl group was removed 
concurrently by the addition of 40 mM Li2CO  3 solution. The resulting 
mixture was acidified using 10% aqueous citric acid and the resulting solid 
was isolated after lyophylization. The pellet was washed successively  with 
water, ethanol, and diethylether. The fine yellow powder thus obtained 
was  ~70%  pure  by  thin  layer  chromatography (Rf  =  0,15)  on  silica 
(Kodak  13181)  using a  mixture of isopropanol, methanol, and concen- 
trated NH4OH of 3:1:1. A  single slower moving impurity (Rf =  0.06) was 
detected which reacted positively with ninhydrine and was assumed to be 
N"pteroyl-L-Lysine based upon its chromatographic retention time. This 
material was employed in the subsequent iodination step without further 
purification. The affinity for Pte-ASA-Lys is similar as for folic acid as 
demonstrated by equimolar competition for MFR-a of [3H]folic acid bind- 
ing by Pte-ASA-Lys and Pte[125I]ASA-Lys binding by folic acid (results 
not shown). 
Photoaffinity Labeling and Endocytosis of MFR-a 
Labeling of MFR-a present at the plasma membrane of KB cells was per- 
formed either by lactoperoxidase-mediated iodination of the cell surface 
as decribed previously (Cerneus et al., 1993) or using a crosslinkable pho- 
toaffinity analog of folic acid, pteroyl-N~-(4-azido-5-[lZSI]iodosalicylyc)-L  - 
lysine (Pte-[125I]ASA-Lys) (Fig. 1). Iodination of 200 p~g Pte-ASA-Lys in 
200  ~1 dimethylformamide was performed as described  by Price  et  al. 
(1986, 1987)  in subdued red light using 1.5 mCi 125I and five iodobeads 
(Pierce,  Rockford, IL). After 30 min at room temperature the solution 
was applied to a fluorescent, silica gel TLC sheet which was developed in 
a mixture of 3:1:1 (vol/vol) isopropanol:methanol:NH4OH. After 3 h Pte- 
[125I]ASA-Lys  (RF:  0.4)  was identified  using short-wave UV light (266 
nm), carefully scraped and extracted in methanol. After pelleting the sili- 
cagel at  13,000  g, the methanol was evaporated under N 2 and the Pte- 
[1251]ASA-Lys was dissolved in 200 ~1 160 mM Hepes, 2 mM MgC12 (pH 
7.4). Aliquots were used to determine the concentration (usually 170-210 
pmol/lxl) in a spectrophotometer at 282 nm and the specific activity (usu- 
ally 2.5-3 nCi/pmol) in a gamma counter. 
For endocytosis, the cells were washed three times with RPMI  1640 
without  folic  acid,  supplemented with 20 mM Hepes, pH  7.3  (RPMI- 
Hepes) on ice. To remove extracellularly bound ligands the cells were 
washed three times on ice with 25 mM Mes, 2 mM CaCI2, 140 mM NaCI, 
pH 4.5, followed by three times with RPMI-Hepes on ice. Next the cells 
were incubated in subdued red light in 50 pmol/ml Pte-[1251]ASA-Lys  in 
RPMI-Hepes for 15 min on ice. The cells were washed three times with 
RPMI-Hepes and irradiated with high intensity 365 nm UV-light (Spec- 
troline SB-100/F, Spectronics Corporation, Westbury, NY) to covalently 
bind the Pte-[125I]ASA-Lys to MFR-a at the cell surface. To remove non- 
specifically incorporated or noncovalently bound Pte-[1251]ASA-Lys,  the 
ceils were washed twice with 25 mM Mes, 2 mM CaCI2, 140 mM NaCI, pH 
4.5 containing 1 mg/ml bovine serum albumin (BSA) as a scavenger mole- 
cule, followed by three times with RPMI-Hepes on ice. Next the cells were 
chased for the indicated periods of time at 37°C in RPMI-Hepes, supple- 
mented with l  nM folinic acid. To distinguish internalized MFR-a from 
MFR-ct at the plasma membrane, the cells were washed once with ice-cold 
RPMI-Hepes, washed twice with ice-cold 25 mM Mes, 2 mM CaCI  z, 140 
mM NaC1, pH 5.5,  and incubated with 50 mU/ml neuraminidase (Boeh- 
ringer, Mannheim, Germany) in the latter buffer for 1 h on ice. To stop 
the neuraminidase-mediated desialylation of proteins at the plasma mem- 
brane,  the  cells were  washed three  times with  PBS  containing 2  mM 
EDTA and 1 mM PMSF and lysed in 1% NP-40 in H20 containing 1 rag/ 
ml sialylated fetuin for 30 rain on ice. Aliquots of the lysates were incu- 
bated in the absence or in the presence of 0.2% saponin on ice and deter- 
gent-insoluble material was removed by centrifugation at 10,000 g at 4°C. 
Counting aliquots of the lysates and the insoluble pellets showed that in 
the presence of saponin no counts were found in the pellets, indicating 
complete  solubilization  of MFR-a  under these conditions. The lysates 
were analyzed on 1 dimensional isoelectric focussing gels with a linear pH- 
range from 3.9 to 8.8 as described previously (Rijnboutt et al., 1992)  and 
visualized by autoradiography. Quantitation of SDS-PAGE and IEF gels 
was performed using a Phospho-Imager (Molecular Dynamics). For IEF 
gels, neuraminidase-sensitive  species of MFR-c~ were quantitated together 
and expressed as a percentage of the total. 
Analysis of Triton X-  l O,O-insoluble Membrane Domains 
on Sucrose Flotation Gradients 
The isolation of Triton X-lOO-insoluble membrane domains on sucrose 
fotation gradients was performed using the method described by Fiedler 
et al. (1993) and Sargiacomo et al. (1993). The cells were labeled with Pte- 
[125I]ASA-Lys as described above. After photoaffinity labeling, described 
as above, the cells were kept on ice or incubated at 37°C in RPMI-Hepes. 
Subsequently, the ceils were washed with ice-cold RPMl-Hepes and lysed 
at 0°C in 1% Triton in 25 mM Tris pH 7.2, 5 mM EDTA, 1 mM PMSF and 
140 mM NaC1 containing 1% Triton X-100 in the absence or the presence 
of 0.2% saponin. In case fractions of Percoll gradients were analyzed, the 
fractions of interest were pooled and vesicles were lysed using Triton X-100 
at a final concentration of 1%. Next 2 ml of the lysate were mixed with 2 
ml 2.4 M sucrose in 25 mM Tris pH 7.2, 5 mM EDTA, 1 mM PMSF and 
140 mM NaCI in an SW41 tube and carefully overlayed with subsequently 
6 ml 1.1 M sucrose and 2 ml 0.15 M sucrose in the same buffer (Beckman 
Instrs., Fullerton, CA). The lysates were fractionated at 100,000 g for 18 h 
at  4°C  and  aliquots  of the fractions were  analyzed using SDS-PAGE. 
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Figure  1.  Chemical  structures 
of the two crosslinkable photo- 
affinity analogs of folic acid and 
methotrexate,  Pte-[I~5I]ASA- 
Lys  and  APA-[lZSI]ASA-Lys, 
respectively. 
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lar Dynamics). For some experiments (as in Fig. 5), CEM-7A cells were 
labeled  with  N~-(4-amino-4-deoxy-10-methylpteroyl)-N~-(4-azido-5-125I  - 
iodosalicylyl)-L-lysine  (APA-[12SI]ASA-Lys),  a photoaffinity analog of the 
antifolate methotrexate constructed for probing the Reduced Folate Car- 
rier (RFC) (Price et al., 1987; Freisheim et al., 1988, 1992) (Fig. 1). Label- 
ing of the RFC at the plasma membrane of 2.107 CEM-7A cells using 
APA-[I25I]ASA-Lys was performed in I ml 160 mM Hepes, 2 mM MgCI2 
(pH 7.4) for 15 rain on ice and followed by irradiation with UV-light. 
Recycling of MFR-a and SubceUular Fractionation 
on Percoll Gradients 
To  study recycling of internalized MFR-tx to the cell surface, KB-ceUs 
were labeled with Pte-[125I]ASA-Lys  as described above and incubated for 
2 h at 37°C with RPMI-Hepes, supplemented with 1 nM leucovorin. Next 
the cells were washed three times with ice-cold RPMI-Hepes followed by 
two incubations of 10 rain with 25 mM Mes, 2 mM CaC12, 140 mM NaCI, 1 
mg/ml BSA, pH 4.5, to remove all extracellularly bound Pte-[~SI]ASA  - 
Lys. After washing three times with RPMI-Hepes, the ceils were irradi- 
ated with UV light as described above and incubated at 37~C for the indi- 
cated periods of time. For some experiments (as in Fig. 7/4),  the cells 
were incubated at 37°C before irradiation with UV light, allowing the re- 
moval of ligand bound to recycled MFR-a with a final acidic wash. Next 
the cells were washed once with ice-cold RPMI-Hepes and once with ho- 
mogenization buffer (0.25 M sucrose, 10 mM Hepes pH 7.2,1 mM EDTA, 
and i mM PMSF). The cells were homogenized on ice in 0.60-ml homoge- 
nization buffer by passing them ten times through a 25-G needle. A post- 
nuclear supernatant was prepared by centrifugation at 300 g for 10 min at 
4°C and 400  I~1 PNS was fractionated on 7.4  ml 20%  Percoll-gradients 
(Pharmacia Fine Chemicals, Piscataway, N.J.) in homogenization buffer, 
by centrifugation at 32,000 rpm (100,000 g) for 25 rain at 4°C in a Beckman 
50Ti  rotor. Pte-[125I]ASA-Lys-labeled MFR-ct was detected in the frac- 
tions by counting in a gamma counter. 
Ultracryotomy and Immunolabeling 
The endocytic pathway was visualized by incubating the cells for I  h with 
BSA-Gold (0 5 nm, final OD 10). Before fixation the BSA-gold was re- 
moved by washing three times with culture medium. Cells were fixed at 
room temperature by adding 1 ml 4% paraformaldehyde, 0.4% glutaral- 
dehyde in 0.1 M phosphate buffer, pH 7.4 to 1 ml medium. After 10 min 
the  fixative/medium mixture  was  replaced  by  2%  paraformaldehyde, 
0.2% glutaraldehyde in 0,1 M phosphate buffer. 50 min later the cells were 
removed from the petri dish using a rubber policeman and transferred to 
an Eppendorf vial. The cells were spun down and washed three times with 
PBS, 0.15  M  glycine, and finally pelleted in  10%  gelatin in phosphate 
buffer. The gelatin was allowed to solidify, and small cubic blocks were cut 
at 4°C and infused with 2.3 M sucrose in phosphate buffer for at least 2 h 
at 4°C. The blocks were mounted on a copper specimen holder and frozen 
in liquid nitrogen. Ultrathin cryosections were prepared on a Leica U1- 
tracut S (Vienna, Austria) and either single labeled for MFR-ct or double 
labeled (Geuze et al., 1981) for the folate receptor and clathfin (Ahle et 
al., 1988). 
The relative distribution of MFR-ct immunoreactive sites was deter- 
mined by counting gold particles over cell profiles containing a Golgi ap- 
paratus and a nucleus. In three different grids 10 profiles were counted. 
The number of gold particles was measured over the plasma membrane 
(including coated pits and caveolae), the endosomal apparatus (tubulo-vesic- 
ular  structures,  endosomes,  multivesicular  endosomes;  all  containing 
BSA-gold), the biosynthetic pathway (RER, Golgi apparatus, trans-Golgi 
reticulum), and other vesicles. 
Results 
Triton X-100 Insolubility of MFR-a during Passage 
through the Golgi Complex 
KB cells, a human nasopharyngeal carcinoma cell line, ex- 
press large amounts (2~. X 107 receptors/cell) of MFR-a 
at their cell surface (McHugh and Cheng, 1979; Antony et 
al., 1985; Luhrs et a1.¢1986; Elwood et al., 1986). The pro- 
tein can be  released completely by PI-PLC (results  not 
shown; Luhrs and Slomiany, 1989) indicating anchoring to 
membranes by a glycosyl-phosphatidyl-inositol (GPI) an- 
chor (Lacey et al., 1989; Alberti et al.,  1990). Several re- 
cent reports indicate that GPI-linked proteins become in- 
soluble  in  the  detergent  Triton  X-100  at  0°C  during 
maturation  of  the  oligosaccharide  chains  (Cinek  and 
Horejsi,  1992;  Brown  and  Rose,  1992;  Dr~berov~i  and 
Dr~iber, 1993; Cerneus et al., 1993; Garcia et al., 1993). To 
study the incorporation of MFR-ot in Triton X-100-insolu- 
ble  membrane  domains,  KB  cells  were  labeled  with 
[35S]methionine  and chased after which the cells were lysed 
in 1% Triton X-100 at 0°C. Aliquots of these lysates were 
then incubated in the presence or absence of the choles- 
terol complexing agent saponin and MFR-et was immuno- 
precipitated and analyzed by SDS-PAGE. 
MFR2 was synthesized as a 32-kD precursor which was 
converted to a 36-38-kD mature species starting after 1 h 
of chase  (Fig. 2 A). This increase in apparent molecular 
weight is due to the conversion of high-mannose N-linked 
oligosaccharide chains to the complex type (Luhrs, 1991). 
The 32-kD precursor of MFR-et remained completely sol- 
uble  in  Triton  X-100,  whereas  after  2  h  of chase  only 
33.7%  _+ 4.8  (n  =  24) of mature MFR-et could be solubi- 
lized in Triton X-100 at 0°C. The solubilization of the full 
complement of mature MFR-et was obtained by the addi- 
Figure 2.  Triton X-100 solubility of biosynthetic species of MFR-a. 
(A) KB cells were labeled with [35S]methionine, chased for the in- 
dicated periods of time and lysed in 1% Triton X-100 in the ab- 
sence (-)  or presence (+)  of 0.2%  saponin at 0°C. The  lysates 
were  immunoprecipitated  for  MFR-a  and  analyzed  by  SDS- 
PAGE.  (B)  KB cells were labeled with [35S]methionine, chased 
for 4 h  and lysed as in A  at 0°C or at 37°C. Protein-aliquots Of the 
lysates  were  analyzed  on  SDS-PAGE.  Apparent  molecular 
weight markers are indicated on the left (kD). 
The Journal of Cell Biology, Volume 132, 1996  38 tion of 0.2%  saponin to the lysate (Fig. 2, A  and B) or by 
incubating  the lysate at 37°C  (Fig.  2 B). Raising the lysis- 
temperature  or  addition  of other  detergents  such  as  1% 
deoxycholate  or  1%  SDS  to the  lysates had  no effect on 
the amount of solubilized material (data not shown). Simi- 
lar  solubilization  characteristics  for  MFR-a  were  also 
found in other cell types indicating  that the effect is inde- 
pendent  of the  expression  level  of  MFR-ot  or  cell  type. 
Since there was already some 36-38-kD  present  after  1 h 
of chase which was completely soluble in Triton X-100 in 
the  absence of saponin  (Fig.  2 A), the transfer of MFR-ct 
to  its  GPI-anchor,  as  well  as  the  formation  of complex- 
type N-linked oligosaccharides  preceded  Triton X-100 in- 
solubility. 
Both MFR-a Pools Present at the Cell Surface 
Are Capable of Binding Ligand 
Next we examined whether these solubilization  character- 
istics were maintained on the cell surface. To this end, the 
cell surface of KB cells was iodinated,  the cells were lysed 
as in  the  previous  experiment  and  MFR-et  was immuno- 
precipitated  and  analyzed  on  SDS-PAGE.  Fig.  3  shows 
that 32.8%  --- 3.3 (n  =  6) of MFR-et was solubilized in Tri- 
ton X-100 at 0°C and that addition  of 0.2%  saponin to the 
lysate  resulted  in  complete  solubilization.  To  determine 
whether all MFR-et present at the cell surface was capable 
of binding ligand, bound ligands were removed by an acid 
wash and the cells were incubated with Pte-[125I]ASA-Lys 
(Fig.  1), an iodinated crosslinkable photoaffinity analog of 
folic acid. After binding, the excess of ligand was removed 
by extensive washing, cross-linking was induced by irradia- 
tion with UV-light and the cells were lysed. Analysis of the 
lysates on SDS-PAGE  shows  (Fig.  3)  that Pte-[125I]ASA - 
Lys-labeled  MFR-a  migrated  as  a  single  band  of 36-38- 
kD.  Solubilization  characteristics  similar  to  125I-lactoper- 
oxidase and [35S]methionine  (Fig. 2)-labeled MFR-et were 
found  (data not shown).  Binding  of Pte-p2SI]ASA-Lys to 
the ceils could be completely prevented in the presence of 
5  IxM folic acid. Taken together, these data show that the 
plasma membrane MFR-et is present in two pools, a Triton 
X-100  soluble  and  insoluble  pool.  Both  of these  MFR-ot 
pools bind  Pte-[125I]ASA-Lys with  a  high  specificity. The 
insolubility  is acquired  during  passage  of the  Golgi-com- 
plex, possibly by incorporation  into Triton  X-100-insolu- 
ble  membrane  domains  (Simons  and  Van  Meer,  1988; 
Brown and Rose, 1992). 
Using  sucrose  flotation  gradients,  Fiedler  et  al.  (1993) 
and Sargiacomo et al. (1993)  have reported that such Tri- 
ton  X-100-insoluble  membrane  domains  were  highly  en- 
riched  in  GPI-linked  proteins  and  caveolin  and  probably 
represent  caveolae.  We  performed  an  analogous  experi- 
ment  using  Pte-[125I]ASA-Lys  as  a  ligand  for  MFR-et  to 
determine  whether Triton X-100 insoluble  MFR-a  in KB 
cells  was  present  in  similar  membrane  domains.  When 
cells  were  lysed  in  Triton  X-100  65-70%  of MFR-ot  was 
found on top of a sucrose flotation gradient (fractions 9-11), 
whereas the soluble fraction remained at the bottom of the 
gradient (fractions 1-5; Fig. 4 A). This shows that the insol- 
Figure 3.  Triton X-100 solubility MFR-ct at the cell surface. The 
cell surface of KB cells was either iodinated followed by immuno- 
precipitation for MFR-a (125I) or KB cells were labeled with Pte- 
[12SI]ASA-Lys in the presence (+) or absence (-) of 5 p~M folic 
acid and lysed as in Fig. 2 A. The immunoprecipitates of 125I-labeled 
cells  and  aliquots  of the  lysates of the  cells  labeled  with  Pte- 
[125I]ASA-Lys were analyzed on SDS-PAGE. Apparent molecu- 
lar weight markers are indicated on the left (kD). 
Figure  4.  Isolation  of  Triton  X-100-insoluble  membrane  do- 
mains  containing  MFR-a.  KB  cells  were  labeled  with  Pte- 
[12SI]ASA-Lys and lysed in Triton X-100 in the  absence (A,  C, 
and D) or presence (B) of 0.2%  saponin. The lysates were frac- 
tionated on sucrose flotation gradients as described in Materials 
and Methods and aliquots of the fractions were analyzed on SDS- 
PAGE. In C and D the cells were allowed to internalize MFR-ct 
labeled with Pte-[125I]ASA-Lys  after which the cells were D  or 
were not C washed with an acidic MES-buffer to remove nonin- 
ternalized ligand. 
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uble plasma membrane domains. After addition  of 0.2% 
saponin  during  lysis  of the  cells  MFR-a  was  recovered 
completely at the bottom of the gradient (Fig. 4 B), show- 
ing that removal of cholesterol interferes with their integ- 
rity, as was previously suggested for alkaline phosphatase 
in the human chorion carcinoma cell line BeWo (Cemeus 
et al., 1993). 
The Reduced Folate Carrier Is Absent  from Triton 
X-lOO-insoluble Microdomains 
Rothberg et al.  (1990)  have proposed that the uptake of 
folates  by  MFR-a  takes  place  in  caveolae  in  a  process 
which  has been  termed  potocytosis. During  this  process 
MFR-ot concentrates  folates in  caveolae after which  the 
folates are translocated to the cytosol by an as yet uniden- 
tified carrier protein.  A  good candidate  protein to fulfill 
this role is the Reduced Folate Carrier (RFC), which has 
been  implicated  in  (anti-)folate  translocation  across the 
plasma membrane and is thought to be an integral mem- 
brane protein  (Dixon et al.,  1994;  Williams et al.,  1994). 
Since the distribution of MFR-a on sucrose flotation gra- 
dients was identical to the  characteristic profile reported 
for GPI-linked proteins and a few integral membrane pro- 
teins (Fiedler et al., 1993;  Sargiacomo et al., 1993; Lisanti 
et al., 1994a), we examined whether the RFC was present 
in Triton X-100-insoluble plasma membrane domains. To 
visualize  the  RFC,  a  similar cross-linkable  photoaffinity 
folate analog was used. This photoprobe (APA-[125I]ASA  - 
Lys; Fig. 1) was based on the antifolate methotrexate, for 
which the RFC has a  high affinity (Jansen et al.,  1990b). 
Based on kinetic studies with (anti-)folates having prefer- 
ential  affinities for either  MFR-a  or the  RFC,  KB  cells 
have been shown to functionally express both MFR-~t and 
the RFC simultaneously, although the RFC is expressed in 
limited  qualitative  amounts  in  KB  cells  (Jansen  et  al., 
1990a;  Westerhof  et  al.,  1991,  1993,  1994).  Therefore, 
APA-[125I]ASA-Lys was used to label the RFC in CEM-7A 
cells,  a  previously  isolated  subline  of  human  leukemia 
CCRF-CEM cells overexpressing the RFC more than 10- 
fold (Jansen et al., 1990b). Next the cells were lysed in Tri- 
ton X-100 at 0°C and run on sucrose flotation gradients. A 
diffuse band of 70--90 kD indicative for the RFC was de- 
tected on SDS-PAGE as shown in previous studies (Freis- 
heim et al., 1988, 1992) and found on the bottom of the su- 
crose  gradient  (Fig.  5).  We  conclude  that  the  RFC  is 
excluded from Triton X-100-insoluble plasma membrane 
domains.  If these domains represent caveolae, RFC can- 
not function in tandem with MFR-a during potocytosis of 
folates (Kamen et al.,  1991).  MFR-c~ was not detected in 
this  experiment  because  CEM-7A  cells  do  not  express 
folate receptors. However, when APA-[12SI]ASA-Lys was 
used to label KB cells, the photoprobe also specifically la- 
beled MFR-a without changing its distribution on the su- 
crose gradient (data not shown). In another control exper- 
iment in which cell surface-iodinated KB cells as well as 
CEM-7A cells were tysed in 1% Triton X-100 and run on 
sucrose  flotation  gradients,  a  small  subset  of  iodinated 
membrane proteins  were  found  on  top  of the  gradients 
whereas the bulk of iodinated material was found on the 
Figure 5.  The reduced folate carrier is absent from Triton X-100- 
insoluble membrane domains. CEM-7A cells, which overexpress the 
reduced folate carrier were labeled using APA-[125I]ASA-Lys  and 
lysed in Triton X-100 at 0°C. The lysate was fractionated on su- 
crose flotation gradients as described in Materials and Methods and 
aliquots of the fractions were analyzed on SDS-PAGE. The 69-kD 
band in lane 10 has been identified  to be serum albumin, which 
has some nonspecific binding capacity for APA-[125I]ASA-Lys. 
bottom, showing the specificity of the flotation procedure 
(data not shown). 
Only Triton X-lOO--soluble MFR-a Is Internalized 
by KB Cells 
Next we studied the internalization of MFR-a in KB cells. 
After removing bound ligands by an acidic wash, the cells 
were labeled with Pte-[lzsI]ASA-Lys, washed and irradi- 
ated with UV-light to covalently link the ligand to MFR-a. 
The cells were allowed to internalize MFR-a for the indi- 
cated  periods  of  time,  washed  on  ice  and  treated  with 
neuraminidase  to distinguish  internalized  from noninter- 
nalized MFR-a. Next the cells were lysed in Triton X-100 
in the absence or the presence of 0.2% saponin and the ly- 
sates were applied to isoelectric focussing (IEF) gels. 
The  results  are  shown  in  Fig.  6.  Again  only  33%  of 
MFR-a was solubilized in the absence of saponin. Without 
chase, treatment of the cells with neuraminidase resulted 
in a complete shift of all isoforms of MFR-a to higher iso- 
electric points. After 1 h of chase a maximum of 12.3%  _+ 
2.8 (n =  3) MFR-a had become resistant to the neuramini- 
dase treatment, indicating these molecules had been inter- 
nalized during incubation of the cells at 37°C. The amount 
of internalized MFR-a was independent of the presence of 
saponin during lysis of the cells, showing that endocytosis 
was limited to the MFR-a molecules soluble in Triton X-100 
in the absence of saponin. We conclude that MFR-a present 
in Triton X-100-insoluble membrane domains did not par- 
ticipate  in  the  internalization.  When  the  protocol of the 
experiment was changed  by cross-linking Pte-[125I]ASA  - 
Lys with UV-light after the  internalization  of MFR-a at 
37°C identical results were obtained, as was the case when 
lactoperoxidase-mediated cell surface-iodination of the cells 
followed  by  immunoprecipitation  of  MFR-a  was  used, 
showing  that  neither  absence  nor  cross-linking  of  the 
ligand to MFR-a interferes with its trafficking (data not 
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cells were labeled with Pte-[125I]ASA  - 
Lys and irradiated with UV-light to co- 
valently  link  the  ligand  to  MFR-m 
Next the cells were allowed to internal- 
ize MFR-a for the indicated  periods of 
time  (hours),  washed  on  ice  and 
treated  with  (+)  or  without  (-) 
neuraminidase to distinguish  internal- 
ized and noninternalized  MFR-a. The 
cells were lysed as in Triton X-100 in 
the  absence  (-)  or  presence  (+)  of 
0.2% saponin and the lysates were ap- 
plied to isoelectric focussing gels with a 
linear pH-range from 3.9 to 8.8. 
shown).  In a  separate  experiment in  which  cells labeled 
with Pte-[12SI]ASA-Lys were allowed to internalize MFR-e~ 
at 37°C for 4 h and subsequently analyzed on sucrose flota- 
tion gradients these data were confirmed (Fig. 4, C and D). 
When extracellularly bound ligands were removed by an 
acidic wash of the cells after the incubation at 37°C, only a 
small amount of MFR-ot was found at the bottom of the 
gradient (Fig. 4 D), again showing that internalized MFR-ct 
was soluble in Triton X-100. 
Internalized MFR-a Recycles to the Plasma Membrane 
Recycling of MFR-t~ was studied by cell-fractionation on 
Percoll density gradients. KB cells were labeled with Pte- 
[125I]ASA-Lys as above, washed and allowed to internalize 
MFR-a  at 37°C for 2  h.  Due to the  high affinity of folic 
acid/Pte-[125I]ASA-Lys for MFR-et  intracellular  dissocia- 
tion of Pte-[125I]ASA-Lys from MFR-a during endocytosis 
is  thought  to  be  negligible  (Kamen et  al.,  1988).  Subse- 
quently noninternalized  ligand was removed by an acidic 
wash and internalized ligand was cross-linked to the recep- 
tor at 0°C by irradiation of the cells with UV-light. Intra- 
cellular Pte-[125I]ASA-Lys-labeled MFR-cx was allowed to 
recycle at 37°C for the indicated periods of time. Postnu- 
clear supernatants were prepared and fractionated on Per- 
coll gradients. 
Fig. 7 A  shows the  distribution  of total cell associated 
Pte-[12SI]ASA-Lys-labeled MFR-e~  after binding  and  in- 
ternalization  of Pte-[125I]ASA-Lys (open  squares).  After 
surface-associated  Pte-[a25I]ASA-Lys had  been  removed 
by an acidic wash, the internalized MFR-a distributed  at 
steady state in two overlapping peaks (fractions 3  and 5; 
solid squares). Subtraction of these curves showed that the 
plasma membrane fractionated in the middle of the gradi- 
ent (fractions 5-6-7). Fig. 7, B-G show that during the in- 
cubation of cells at 37°C,  internalized MFR-et was slowly 
but progressively transported from the  intracellular pool 
in fraction 3 to the plasma membrane in fraction 6 (solid 
squares),  when compared to the intracellular distribution 
at steady state (open squares).  In a parallel experiment in 
which the irradiation  of the cells with UV-light was per- 
formed after the chase incubation at 37°C (i.e., after recy- 
cling),  identical  distributions  for  recycling  MFR-et  were 
found  (data not shown).  This again indicated  that cross- 
linking of Pte-[125I]ASA-Lys to MFR-tx did  not interfere 
with  its  intracellular  transport.  However, this  procedure 
allowed the release of ligands bound to recycled MFR-~x 
by an  acidic  wash  after  the  chase  period  (Fig.  7  //).  It 
shows  that  part  of MFR-ct  had  recycled  to  the  plasma 
membrane.  However,  the  majority  of internalized,  Pte- 
p25I]ASA-Lys-labeled MFR-ct was retained in intracellu- 
lar compartments (Fig. 7 H) and was not triggered to recy- 
cle to the plasma membrane by longer chase periods (not 
shown). We conclude that part of the internalized MFR-et 
recycles slowly to the plasma membrane whereas the ma- 
jority  remains  in  intracellular  compartments and  is  pre- 
sumably degraded. 
Since previous experiments had shown that only Triton 
X-100 soluble MFR-et participated in endocytosis, we de- 
termined the Triton X-100 solubility of recycling MFR-c~ 
on sucrose  flotation  gradients  at  all chase times used in 
Fig. 7. Therefore, Triton X-100 was added to fractions 2-3-4 
(Fig. 8, A and C) or fractions 6-7-8 (Fig. 8, B and D) of the 
Percoll gradients to a final concentration of 1% and the ly- 
sates of the pooled fractions were applied to sucrose flota- 
tion gradients  as the cell lysates in Fig. 4.  The results of 
two of these experiments are shown in Fig. 8. After a chase 
of 5 min (Fig. 8, A  and B) and after a chase of 60 min (Fig. 
8,  C  and D), as well as at the  other periods of time (not 
shown), more than 90%  of MFR-o~ was recovered at the 
bottom  of  the  gradient.  This  indicates  that  MFR-et  re- 
mained soluble in Triton X-100 during its recycling to the 
plasma membrane and that movement of MFR-a from the 
Triton X-100  soluble pool to the Triton X-100  insoluble 
pool only occurred very slowly. 
Immunoelectron Microscopy 
Finally, the intracellular distribution of MFR-et in KB cells 
was examined using immunolocalization in  the  electron- 
microscope.  The  cells  were  fixed  and  ultrathin  cryosec- 
tions  were  immunolabeled  for  MFR-oL. Fig.  9  A  shows 
abundant homogeneous labeling for MFR-c~ at the plasma 
membrane and in budding vesicles. The relative distribu- 
tion  of MFR-a  immunoreactive  sites  (Table  I)  showed 
that almost 90% of the receptor is present at the cell sur- 
face. Based on morphological criteria, caveolae were de- 
tected only incidentally in KB cells. Most of the budding 
vesicles at the plasma membrane were clathrin-coated pits, 
which  colabeled for MFR-et  (Fig.  9  B).  9.3%  of MFR-c~ 
was also found in a variety of large and small endosomes 
(Fig. 9, C and D). Only 2% of the MFR-et immunoreactive 
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Figure 7.  Recycling of internalized MFR-a to the plasma membrane. KB cells were labeled with Pte-[125I]ASA-Lys and allowed to in- 
ternalize MFR-et at 37°C. Noninternalized MFR-et was stripped by an acid wash, the cells were irradiated with UV-light to covalently 
link internalized ligand to MFR-ct and chased for the indicated periods of time (minutes). Next a postnuclear supernatant was fraction- 
ated on Percoll gradients and fractions were counted in a Gamma counter. (A) Distribution of total MFR-u and the distribution of inter- 
nalized  MFR-ct  after an acid wash.  (B-G) Time course  of changes in the distribution of intracellutar and recycling MFR-a  (filled 
squares) as compared to the distribution before the chase (open squares). (H) Distribution of intracellular MFR-ct before (open squares) 
and after (filled squares) the chase period. In this case the irradiation with UV light was performed after a final acid wash at the end of 
the chase period. 
The Journal of Cell Biology, Volume 132, 1996  42 Figure 8.  Analysis of recycling MFR-a on sucrose flotation gradi- 
ents. Top and bottom fractions of Percoll gradients shown in Fig. 
7 C (chase = 5 min) and Fig. 7 G (chase = 60 min) were pooled. 
The pooled fractions  were lysed in 1% Triton X-100 and sub- 
jected to sucrose flotation gradient centrifugation.  Distributions 
were visualized by analysis on SDS-PAGE.  (A) Bottom fractions 
2-3-4; chase = 5 min. (B) Top fractions 6-7-8; chase = 5 min. (C) 
Bottom fractions 2-3-4; chase = 60 min. (D) Top fractions 6-7-8; 
chase = 60 min. 
sites was found along the biosynthetic pathway (RER and 
Golgi complex) (Fig. 9 E). 
Taken  together,  the  present  study  provides  evidence 
that only small amounts of MFR-ct are slowly internalized 
and recycled to the plasma membrane by KB cells. Inter- 
nalized MFR-ot has access to the entire endocytic appara- 
tus, probably after internalization by clathrin-coated vesi- 
cles.  MFR-ct  present  in  large  Triton  X-100-insoluble 
membrane domains remain at the plasma membrane. 
Discussion 
In the present study the biosynthesis and endocytosis of 
MFR-ot and its recycling to  the plasma  membrane were 
studied with respect to its partial insolubility in the deter- 
gent Triton X-100, as found for other GPI-linked proteins 
(Cinek and Horejsi, 1992; Brown and Rose, 1992; Sargia- 
como et al., 1993; Fiedler et al.,  1993; Chang et al., 1994). 
We found that 65-70% of MFR-et becomes insoluble dur- 
ing biosynthetic transport to the plasma membrane, prob- 
ably in the Golgi complex. At the plasma membrane only 
soluble  MFR-a  participates  in  endocytosis.  Internalized 
MFR-a remains soluble in Triton X-100, also after MFR-a 
has recycled to the plasma membrane. Internalization of 
MFR-e~  and its recycling to  the plasma  membrane were 
limited to only 10-15% of MFR-a present at the cell sur- 
face. This is in good agreement with the quantitative im- 
munoelectron microscopy, in which  87%  of the  MFR-et 
was  found  at  the  cell surface  and  only 10%  in  the  en- 
docytic compartments. 
The molecular basis for the distribution of GPI-linked 
proteins  in  two  pools characterized by their differential 
solubilization in  detergents  such  as  Triton X-100  is  not 
well understood. Intramolecular differences of GPI-linked 
proteins present in either one of these pools have not been 
detected. This study shows that the distribution over these 
two pools is independent of the binding of ligand to GPI- 
linked MFR-ct. As several groups have already indicated, 
we conclude that the microenvironment of these proteins 
must be responsible for the solubilization characteristics of 
these proteins. This was indicated by the complete solubi- 
lization  of MFR-ct  after the  addition  of the  cholesterol 
complexing agent saponin to the Triton X-100, indicating a 
key role for cholesterol in the integrity of insoluble mem- 
brane domains (Rothberg et al.,  1990; Brown and Rose, 
1992;  Cerneus et al., 1993). Glycosphingolipids have also 
been suggested to be a critical constituent of Triton X-100- 
insoluble microdomains (Brown and Rose, 1992). The ho- 
mogeneous labeling for MFR-et at the plasma membrane 
as detected in our immunoelectronmicroscopy, suggested 
the presence  of small  rather  than  large  insoluble  mem- 
brane domains. The possibility that the formation of large 
insoluble domains is induced during solubilization in Tri- 
ton X-100 by clustering of individual GPI-linked proteins 
or small insoluble domains cannot be excluded. Since only 
part of the GPI-linked proteins becomes trapped in these 
domains, the fact remains that there must still be a differ- 
ence leading to the differential solubilization. These bio- 
chemically defined microdomains share many characteris- 
tics  of  the  morphologically  defined  caveolae,  however, 
differences in composition due to the methodology used 
cannot be excluded. 
Almost 90% of total cell-associated MFR-a was homo- 
geneously distributed  at  the plasma  membrane.  MFR-a 
was found to colocalize with clathrin in coated pits. A sim- 
ilar localization has been observed for the GPI-linked a2- 
macroglobulin receptor (Nykjzer et al., 1992).  In addition, 
neuroblastoma  cells lacking caveolae and  caveolin have 
been reported to internalize a  glycolipid-anchored prion 
protein via clathrin-coated pits and vesicles (Shyng et al., 
1994).  This is in contrast with the observation that GPI- 
linked proteins are excluded from clathrin-coated pits (Le- 
mansky et al., 1990). MFR-a was also detected along the 
entire  endocytic  pathway  using  immunoelectronmicros- 
copy. These observations are in contrast with the localiza- 
tion  of MFR-et  described  by Rothberg  et  al.  (1990)  in 
MA104 monkey kidney cells. These authors found MFR-a 
uniquely in large clusters in caveolae at the plasma mem- 
brane. Such large clusters of MFR-a in caveolae were not 
detected in prefixed KB cells. On the other hand, cell sur- 
face immunolabeling of unfixed KB cells resulted in large 
clusters of MFR-et at the plasma membrane, which only 
occasionally colocalized with caveolae (data not shown). 
Rijnboutt et al. Endocytosis of  Folate Receptors  43 Figure 9.  Immunolocalization of MFR-a in ultrathin cryosections of KB ceils. Ultrathin cryosections of cultured KB cells which were in- 
cubated with BSA coupled to 5-nm gold particles for 1 h before fixation. The sections were immunolabeled with anti-(MFR-a) and pro- 
tein A-coupled gold particles (Au). (A) Abundant and homogeneous labeling for MFR-a (10 nm Au) at the plasma membrane (PM) 
and in small invaginations of the plasma membrane, presumably clathdn-coated pits (arrowheads). (B) MFR-a (15 nm Au) colocalizes 
with clathrin (10 nm Au) in clathrin-coated pits (arrowheads) at the plasma membrane. (C and D) MFR-a (10 nm Au) was found in a 
variety of small and large, endocytic structures (containing BSA coupled to 5 nm Au). (E) Abundant labeling for MFR-a in the Golgi 
stack (G) and in the trans-Golgi network (7). Bars: (A) 200 nm; (B) 100 rim; (C) 200 nm; (D) 250 nm; (E) 200 nm. 
The Journal  of  Cell Biology,  Volume 132, 1996  44 Table L Relative Distribution  of  MFR-a Immunoreactive  Sites in KB Cells as Measured with lmmunoelectron Microscopy  on 
Ultrathin Cryosections 
Number of cells  Plasma membrane  Endocytic compartment  Biosynthetic compartment  Miscellaneous 
Exp 1  10  88.18  9.00  1.87  0.99 
Exp 2  10  84.75  11.30  2.49  1.46 
Exp 3  10  90.25  7.59  1.43  0.73 
Average  87.71  9.30  1.93  1.06 
SEM  1.60  1.08  0.31  0.21 
The relative distribution was determined by counting the gold particles found over each cell profile. From that the relative distribution was calculated and averaged over 10 cells. 
Plasma membrane: Plasma membrane, coated pits, and caveolae. 
Endocytic compartment: Small tubulo-vesicular structures, endosomes, multivesicular endosomes. 
Biosynthetic compartment: Rough endoplasmatic reticulum, Golgi complex, and trans-Golgi reticulum. 
Miscellaneous vesicles: Vesicles which could not be assigned to one of the previously defined categories. 
This is in good agreement with the study of Mayor et al. 
(1994), in which the authors showed that the clustering of 
MFR-a in monkey kidney MA104 cells was induced by the 
application of the anti-MFR antibody to the cell surface of 
unfixed  cells.  Therefore,  the  different  localizations  of 
MFR-a  found by the  different groups arise from differ- 
ences in the methods used. 
Triton X-10(Oinsoluble membrane domains have been 
suggested  to  represent  caveolae, which  are  enriched in 
GPI-linked proteins  (Fiedler et al.,  1993;  Sargiacomo et 
al.,  1993)  including  MFR-ct  (this  study).  Caveolae have 
been proposed to function in the uptake of folates in a 
process which has been termed potocytosis. In this process 
folates are concentrated by the clustering of folate recep- 
tors in caveolae, which close without pinching off and sub- 
sequently acidify causing the folates to dissociate from the 
receptors. The folates would then enter the cytosol by the 
action of an as yet unidentified folate transporter (Roth- 
berg et al.,  1990;  Anderson,  1993a).  The RFC  has been 
shown  to  be  capable  of translocating  folates across  the 
membrane into the cytosol. In our experiments the RFC 
distributes on the bottom of the sucrose flotation gradients 
and is  excluded from the  detergent resistant  membrane 
domains. This indicates that the RFC is not a likely candi- 
date to act in tandem with MFR-ot in caveolae to translo- 
cate folates into the cytosol. The RFC has been shown to 
be capable of translocating folates directly at the plasma 
membrane without an obligatory concentration of the vi- 
tamin by MFRs before translocation (Sirotnak, 1985; Jan- 
sen et al., 1990b), even under conditions where folate up- 
take  via  MFR-et  was  blocked  (Westerhof  et  al.,  1991, 
1994).  In addition, several cell lines have been identified 
which lack MFRs but express an active RFC, such as the 
CEM-7A cells used in this study. On the other hand, the 
fact that cells can survive by means of a GPI-linked folate 
receptor is illustrated by a previous study in which human 
leukemia cells with a defective RFC were shown to grow 
under nanomolar concentrations of folates (Jansen et al., 
1989b). Therefore, it has been proposed that the RFC is 
the  preferred folate-uptake system in  cells  that  express 
both systems (Westerhof et al., 1993, 1994), although cells 
lacking  the  RFC  can  accumulate  sufficient  amounts  of 
folates to grow by means of MFRs. 
The fact that MFR-a has a GPI anchor opens the possi- 
bility for a role in signal transduction cascades, as has been 
suggested for other GPI-linked proteins such as Thy-1 and 
Decay Accelerating Factor (Stefanov~i  et al., 1991; Shenoy 
et al., 1992; Thomas and Samuelson, 1992; Dr~iberov~ and 
Drfiber, 1993). GPI-anchored MFRs have also been impli- 
cated  in  signal  transduction  causing  a  proliferative  re- 
sponse in hematopoietic progenitor cells (Antony et al., 
1987,  1991) and an increased transient uptake of Ca  2+ in 
Dictyostelium DiscoYdeum (Milne and Coukell, 1991). Re- 
cently, it has been suggested that caveolae function as a 
specialized region of the plasma membrane for Ca  2+-homeo- 
stasis and signal transduction (Anderson, 1993a,b; Lisanti 
et al., 1994b). In contrast to this hypothesis is the report by 
Fra et al. (1994) in which the authors show the presence of 
detergent-insoluble glycolipid domains in cells devoid of 
caveolae and caveolin. 
In conclusion, we feel that the role of GPI-linked MFRs 
in the uptake of (anti-)folates is subordinate to the role of 
the RFC. This does not alter the fact that MFRs can be 
used to introduce antifolate compounds (ZD1694, CB3717, 
and DDATHF) with high affinity for MFRs into neoplas- 
tic cells, such as in ovarian cancer in which MFR-et has 
been suggested to be a marker protein because of its con- 
stant high level of expression (Campbell et al., 1991). The 
possible role of MFRs in signal transduction cascades in- 
volved in cell proliferation offers exciting new possibilities 
for investigation. 
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